Results 171 to 180 of about 73,229 (226)
Some of the next articles are maybe not open access.

THE AMINOGLYCOSIDES

Obstetrics and Gynecology Clinics of North America, 1992
The three most commonly used aminoglycosides in obstetrics and gynecology are gentamicin, tobramycin, and amikacin. These drugs bind to subunits of the ribosome and inhibit bacterial protein synthesis. They are primarily active against aerobic gram-negative bacilli.
openaire   +2 more sources

Aminoglycoside Antibiotics

Audiology and Neurotology, 2000
In the 50 years since their discovery, the aminoglycoside antibiotics have seen unprecedented use. Discovered in the 1940s, they were the long-sought remedy for tuberculosis and other serious bacterial infections. The side effects of renal and auditory toxicity, however, led to a decline of their use in most countries in the 1970s and 1980s ...
A, Forge, J, Schacht
openaire   +2 more sources

The Aminoglycosides

Clinical Orthopaedics and Related Research, 1984
Aminoglycoside antibiotics continue to be indispensable in the management of complex aerobic gram-negative infections. In the United States approximately 4,000,000 patients receive this antibiotic class each year. Although the clinical efficacy of aminoglycosides is unsurpassed, these antibiotics nonetheless have an inherent tendency to produce ...
openaire   +2 more sources

Aminoglycosides in urology

Urology, 1990
Prompt management of serious urologic infections is extremely important. Kreger e t a l . 1 have ~emonstrated that early therapy with an effective antibiotic will result in improved survival ~nd a lower frequency of shock associated with :gram'negative baeteremia.
openaire   +2 more sources

Aminoglycoside ototoxicity

Drugs of Today, 2003
Over the last 10 years new information has been published providing a better understanding of the risk factors, mechanism and prevention of aminoglycoside ototoxicity. The use of a higher dose and once-daily intravenous administration of aminoglycosides has shown clinical effectiveness with no increase in ototoxicity when compared to traditional ...
openaire   +2 more sources

Aminoglycoside Ototoxicity

American Journal of Otolaryngology, 1980
Aminoglycoside antibiotics are frequently employed in the treatment of serious infections caused by aerobic gram negative bacilli. The use of these potent antibacterial agents is limited by the risks of ototoxicity and nephrotoxicity. Aminoglycosides are excreted by glomerular filtration at a rate proportional to the serum concentration. Impaired renal
S A, Lerner, G J, Matz
openaire   +2 more sources

Aminoglycoside nephrotoxicity

The American Journal of Medicine, 1990
The high incidence of associated nephrotoxicity represents an important concern in the use of aminoglycoside antibiotics, which have been implicated as one of the primary causes of drug-induced acute renal failure. Several factors, including the underlying health of the patient, criteria used to define nephrotoxicity, and the specific aminoglycoside ...
openaire   +2 more sources

Pharmacokinetics of Aminoglycosides in the Newborn

Current Pharmaceutical Design, 2012
Aminoglycosides have played a major role in antimicrobial therapy since their discovery in the 1940s. Their bactericidal efficacy in gram-negative infections, synergism with beta-lactam antibiotics, limited bacterial resistance, and low cost have given these agents a firm place in antimicrobial treatment. After penicillins, aminoglycosides are the most
van den Anker, Johannes N.   +1 more
openaire   +4 more sources

The Aminoglycoside Panel

Therapeutic Drug Monitoring, 1983
The aminoglycoside antibiotics gentamicin and tobramycin have been monitored traditionally by measuring peak and trough drug levels in serum. We found interpretation of these data to be hazardous, due to variations in the drug administration-specimen collection process and routine medical events and practices.
J E, Gorsky, J R, Latts
openaire   +2 more sources

Aminoglycoside ototoxicity

American Journal of Otolaryngology, 1986
The author participated in two prospective studies of patients receiving aminoglycoside antibiotics. In the first study, 54 patients received amikacin, and 54 received gentamicin. In the second study, 61 patients received gentamicin, 50 received netilmicin, and 52 received tobramycin.
openaire   +2 more sources

Home - About - Disclaimer - Privacy